LEADER 01939oam  2200577   450 
001 9910715256903321
005 20210902125723.0
035   $a(CKB)5470000002509455
035   $a(OCoLC)1232237082
035   $a(EXLCZ)995470000002509455
100   $a20210122g20209999  ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPrescription Drug Sunshine, Transparency, Accountability and Reporting Act $ereport (to accompany H.R. 2113) (including cost estimate of the Congressional Budget Office)
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d2020-
215   $a1 online resource (volumes)
225 1 $aRept. / 116th Congress, 2d session, House of Representatives ;$v116-688
300   $a"December 24, 2020"--Pt. 1.
320   $aIncludes bibliographical references.
517   $aPrescription Drug Sunshine, Transparency, Accountability and Reporting Act 
606   $aPrescription pricing$zUnited States
606   $aPharmaceutical industry$zUnited States
606   $aMedicare
606   $aMedicare$2fast
606   $aPharmaceutical industry$2fast
606   $aPrescription pricing$2fast
607   $aUnited States$2fast
608   $aLegislative materials.$2fast
608   $aLegislative materials.$2lcgft
615  0$aPrescription pricing
615  0$aPharmaceutical industry
615  0$aMedicare.
615  7$aMedicare.
615  7$aPharmaceutical industry.
615  7$aPrescription pricing.
676   $a1.1/8:116-688
801  0$bGPO
801  1$bGPO
801  2$bOCLCO
801  2$bDWP
801  2$bOCLCF
801  2$bGPO
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910715256903321
996   $aPrescription Drug Sunshine, Transparency, Accountability and Reporting Act$93440857
997   $aUNINA